Prestige BioPharma Limited (KRX:950210)
12,850
-120 (-0.93%)
Dec 30, 2025, 3:30 PM KST
-9.51% (1Y)
| Market Cap | 154.45B |
| Revenue (ttm) | 14.41B |
| Net Income (ttm) | 15.76B |
| Shares Out | 12.02M |
| EPS (ttm) | 262.37 |
| PE Ratio | 48.98 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 41,642 |
| Average Volume | 121,026 |
| Open | 13,040 |
| Previous Close | 12,970 |
| Day's Range | 12,690 - 13,150 |
| 52-Week Range | 11,000 - 20,000 |
| Beta | 0.97 |
| RSI | 49.20 |
| Earnings Date | Feb 27, 2026 |